... Methylphenidate and if-thenplans are comparable in modulating the P300 and increasing responseinhibition in children with ADHD. ADHDAttentionDeficit and Hyperactivity Disorders 2010.61. Durston S, Tottenham ... Processing Disorder (APD)and AttentionDeficitHyperactivityDisorder (ADHD) : A Conceptual,Theoretical, and Practical Framework. In An introduction to auditoryprocessing disorders in children. ... pre-vious findings, as no other studies have investigatedbrain activation during antisaccades in children with ADHD. However, it should be noted that there areinconsistent findings in imaging studies...
... A: Attention- deficitdisorder (attention- deficit/ hyperactivity disorder without hyperactivity) : a neurobiologically and behaviourallydistinct disorder from attention- deficit/ hyperactivitydisorder ... functionalimpairment in a clinically referred sample of adults with attention- deficit/ hyperactivitydisorder (ADHD) . Eur Arch Psychiatry Clin Neurosci2007, 257(7):371-377.5. Eme RF: Attention- deficit/ hyperactivity ... core symptoms of ADHD are inattention, hyperactivity andimpulsivity. Further, deficits in executive functioning arecommonplace, such as planning, organising, exerting self-control, working...
... E: Gen-der effects on Attention- Deficit/ Hyperactivitydisorder in adults, revisited. Biol Psychiatry 2004, 55:692-700.56. Biederman J: Attention- Deficit/ Hyperactivity Disorder: ASelective Overview. ... Monu-teaux M: Can adults with attention- deficit/ hyperactivity disor-der be distinguished from those with comorbid bipolar disorder? Findings from a sample of clinically referred adults. Biol Psychiatry ... Schwitzgebel P, Pinhard K, Dovi-Akue N, Wender P, et al.:Prevalence of attention deficit- /hyperactivity disorder (ADHD) and comorbid disorders in young male prisoninmates*. Eur Arch Psychiatry Clin Neurosci...
... michael.schlander@innoval-hc.comAbstractBackground: During the last decade, pharmaceutical spending for patients with attention- deficit- hyperactivity disorder (ADHD) has been escalating internationally.Objectives: ... ofwhich ranked among the top-100 products in terms ofsales [44]. In England spending for ADHD- related pharmacother-apy, including modafinil and atomoxetine, increasedfrom 1998 (3.1 million) to ... Fine EM: Increased methylphenidate usage for attention- deficitdisorderin the 1990s. Pediatrics 1996,98(6):1084-1088.7. Shatin D, Drinkard CR: Ambulatory use of psychotropics byemployer-insured...
... adults& apos; requests21 Has trouble concentrating in class22 has difficulty waiting in lines or awaiting turn in games or group situations23 Leaves seat in classroom or other situation in ... playingvideo games. It would be interesting to examine the lattercohort in more detail to determine if there is a linear rela-tionship between time spent playing video games and ADHD symptoms ... analysis of video games and attentiondeficit hyperactivity disordersymptomsin adolescentsPhilip A Chan*1 and Terry Rabinowitz2Address: 1Department of Internal Medicine, Rhode Island Hospital,...
... whether there are sustainable improve-ments inADHD clinical symptoms and neurocognitivefunction in realistic clinical settings. Second, whetherthe differences inADHD clinical symptoms and neuro-cognit ... attention deficit hyperactivitydisorder (ADHD) clinical symptoms and neurocognitive function in a realistic clinical setting, and thedifferences inADHD symptom improvement using different classifications ... and combined t ype, according to the predomi-nant clinical manifestations of inattention, hyperactivity, and impulsivity. The validity of DSM-IV ADHD predo-minantly inattentive and combined types...
... Tasha M Burwinkle - tburwinkle@swmail.sw.org* Corresponding author AbstractBackground: Attention- Deficit/ HyperactivityDisorder (ADHD) is the most common chronicmental health condition in children ... males with attention- deficit hyperactivity disorder. Journal of Attention Disorders 2004,7:163-173.21. Landgraf JM, Abetz LN: Functional status and well-being of chil-dren representing three ... populations has severaldistinct benefits beyond the clinical setting. It can aid in identifying subgroups of children who are at-risk forhealth problems, in determining the burden of a particu-lar...
... in the UK for the management of ADHDin school-age children and young people, and are effective in controlling ADHDsymptoms [9]. The guidelines produced by the UK National Institute of Clinical ... [2]. Furthermore, learning difficulties [3] and impairment in social functioning [4] are frequently observed in patients with ADHD. The symptoms of ADHD decline with increasing age, and although ... obvious, but equally impairing, in older adolescents. Notable risk factors for developing ADHD include family history of ADHD [7], preterm birth and smoking or drinking during pregnancy [8]. ...
... efficacy in helping smokers with attentiondeficithyperactivitydisorder (ADHD) to stopsmoking.Methods: To investigate potential efficacy for relieving nicotine withdrawal symptoms and promoting ... 6smoking in adult non -ADHD smokers who were nottrying to stop smoking [5,6]. To date, the only large trialof methylphenidate in smokers has been in smokerswith AttentionDeficitHyperactivityDisorder ... dopamine by binding tothe dopamine transporter in the presynaptic cell mem-brane and increase extracellular dopamine levels [2,3].Similarities in neuropsychologic effects between nicotineand...
... mara.hutz@ufrgs.br ADHD, attention- deficit/ hyperactivity disorder; BAIAP2, brain-specific angiogenesis inhibitor 1-associated protein 2 gene; BDKRB2, brady-kinin receptor B2 gene; DAT1, dopamine transporter ... catecholaminergic pathways in the brain are responsible for ADHD. However, many negative association findings have been reported, indicating a limited success for investigations using this ... need to be considered when defining candidate genes for ADHD association studies.IntroductionAlthough the etiology of attention- deficit/ hyperactivity disorder (ADHD) is not completely understood,...
... blind trials, comparing efficacy of methylphenidate withatomoxetine, in treatment of ADHDin children, diagnosed using DSM-IV™ criteria were included. The outcome studiedwas ADHDRS-IVParent:Inv ... 57:1215-1220.2. Del Campo N, Chamberlain SR, Sahakian BJ, Robbins TW: The Roles ofDopamine and Noradrenaline in the Pathophysiology and Treatment of Attention- Deficit/ Hyperactivity Disorder. Biol Psychiatry ... trials. Definitionof response varied betw een trials. Five studies definedresponse as a ≥40% reduction from baseline to endpoint in the ADHDRS-IV-Parent:Inv [ 20,21,28,29]. One studydefined response...
... in future molecular studies.Background Attention DeficitHyperactivityDisorder (ADHD) is acommon neurodevelopmental disorder characterised bypervasive, age inappropriate behaviours of inattention, hyperactivity ... genes in DSM-IV combinedtype attentiondeficithyperactivity disorder: association signals in DRD4,DAT1 and 16 other genes. Mol Psychiatry 2006, 11(10):934-953.31. Brookes KJ, Mill J, Guindalini ... Fitzgerald M, Gill M: Synaptosomal-associatedprotein 25 (SNAP-25) and attentiondeficithyperactivity disorder (ADHD) : evidence of linkage and association in the Irish population. MolPsychiatry 2002,...
... withAttention -Deficit/ HyperactivityDisorderin theUnited Kingdom. Value Health 2008, 11(3):376-388.28. Brown TE: Emerging Understanding of Attention- Deficit Disorders andComorbidities in Attention- Deficit Disorders ... Corresponding author AbstractBackground: Attention Deficit/ HyperactivityDisorder (ADHD) is a neurobehavioural disorder, affecting 3–6% of school age children and adolescents in Spain. Methylphenidate ... modelled economic evaluation comparing atomoxetine with methylphenidate in the treatment of children with attention- deficit/ hyperactivitydisorderin SpainJihyung Hong*1,2, Tatiana Dilla3...
... responders; ADHD- RS-IV-Parent:Inv, ADHD Rating Scale Parent Report Investigator Rated; WREMB, Weekly Ratings Evening and Morning Behaviors. Note: Overall effect size was from baseline to study end-point ... of a clini-cal trial design. In a study optimizing the treatment of ADHD in 25 adults, the combination of atomoxetine andmethylphenidate resulted in small statistically significantmean increases ... their ADHD symptoms following the 10-week atomoxetine treatment.On each measure, patients significantly improved in theircore ADHDsymptoms while taking atomoxetine and pla-cebo during the...